StockData
Artiva Biotherapeutics, Inc. logo

Artiva Biotherapeutics, Inc. (ARTV) stock

ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.96−0.05 (-1.25%)

Close on Nov 16, 2026Market cap $193.61MP/E –Yield –

Artiva Biotherapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Artiva Biotherapeutics

Artiva Biotherapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Artiva Biotherapeutics figures

See a number that looks wrong?